Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.
about
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodiesCrystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1Is audio computer-assisted self-interview (ACASI) useful in risk behaviour assessment of female and male sex workers, Mombasa, Kenya?Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.Mobility, risk behavior and HIV/STI rates among female sex workers in Kaiyuan City, Yunnan Province, China.Impact of antiretroviral therapy on health-related quality of life among South African women in the CAPRISA 002 acute infection study.Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.The Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system.HIV prevention in high-risk women in South Africa: condom use and the need for change.Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression.Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infectionThe search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: progress to date and new avenues for discovery.Loss to follow-up as a competing risk in an observational study of HIV-1 incidenceHIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trialChallenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testingRecruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trialRapid disease progression in HIV-1 subtype C-infected South African women.Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies.Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypesInfluence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infectionVirological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individualsInterleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesisA cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan AfricaLimited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infectionStabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier.Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression.Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.
P2860
Q24613572-BA86B585-70D8-4A34-9638-E61E188949CCQ27644515-1CADD178-E512-4773-9B6D-76325EEE7A27Q27662167-53FF16EA-DB9F-477B-ADF9-DF7CDAA590A6Q28475426-E8EF0192-D20C-4833-A120-688E95DFACF3Q30485614-11D9846C-608A-4225-A699-06C36549BD3FQ30854994-F980C2F9-5410-4937-81D9-8C66AA74EBACQ33504604-103E3662-9244-4BD2-99F7-7AD1FC7218F9Q33606936-9CF8AD90-AF52-4580-9E74-A5D9EF152105Q33628182-D82A16D3-7E09-4564-8A3E-C8D1424C7359Q34021927-AE2237AD-9733-45E1-A760-378AF7C3848FQ34042758-FFF32E8A-A3F4-47F0-A5D8-7F9B17C36D4FQ34157332-B4D7A5BE-3F4B-4A77-B683-5FAEAB0B15A8Q34170153-FFD64E2D-0DEE-4D55-80D8-6862FB4C4D1AQ34295981-7AC590EE-309C-4FC5-821C-E77B780BB6CAQ34402041-E42A9E7C-46A9-4167-BF39-9272BA4BF73EQ34455457-88A7DBE3-AE58-4959-9F18-F230067E5A96Q34458011-4A568215-90CA-4ABE-AAE7-2EA7BA66CCFEQ34561371-EB51279B-AE37-4BA8-A8CF-6E1F723AC5B3Q34649232-26BA906A-8AC5-472B-8ACF-90E9A7B09613Q34674930-CE9C8180-2347-4D66-8B42-DA8BD3BD2162Q34706934-64351B0E-F648-44A9-A4C5-602FAAA1B837Q34712820-292A3454-F477-4201-88A2-CE49DAD63546Q34736181-145CCF0A-A0FB-4CDB-9D20-952DED1B9426Q34742533-701A27A1-03BA-4E27-8F59-611DEEEB06F4Q34858876-AFF38B34-5390-44E7-ADF6-423FAFF8A138Q35034268-C7941F0E-F1B1-4465-8DDB-92F500C00407Q35076519-9D2B0A7D-4E62-4F99-91A8-7B554FEE2FB9Q35076717-43CD6452-33EC-4BE8-A017-C51D8671E081Q35077768-916BD4CE-5C1B-4A8B-93BC-B0C254E244B1Q35109877-705400B1-5B6A-4460-83E6-EF875E2C8CA8Q35126864-3A10BBEB-A4AD-430B-B297-FD5BA7C58086Q35164457-A50C4051-A9E9-49DA-8D08-B61692A3F31DQ35165313-5E7F2DD0-8ADE-4119-BB9C-2A7FF9DEF291Q35508247-15342397-A50D-41DD-BA2C-601EDE5FA27EQ35584999-6063AC85-A46E-490A-A652-91A1CAAA8122Q35600919-906430C6-B98A-47E4-B255-89FA74807DF9Q35628640-ECDE1990-697F-4A5C-8CF0-BA94E5D2A0F4Q35672336-64935F13-378A-4AC9-99DB-AD5DFF4F463EQ35683986-64F1338E-119C-43FF-B327-A313031FB866Q35715634-72F49F55-EA46-4857-8D2E-DE56312B47D6
P2860
Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Establishing a cohort at high ...... ISA 002 acute infection study.
@ast
Establishing a cohort at high ...... ISA 002 acute infection study.
@en
Establishing a cohort at high ...... ISA 002 acute infection study.
@nl
type
label
Establishing a cohort at high ...... ISA 002 acute infection study.
@ast
Establishing a cohort at high ...... ISA 002 acute infection study.
@en
Establishing a cohort at high ...... ISA 002 acute infection study.
@nl
prefLabel
Establishing a cohort at high ...... ISA 002 acute infection study.
@ast
Establishing a cohort at high ...... ISA 002 acute infection study.
@en
Establishing a cohort at high ...... ISA 002 acute infection study.
@nl
P2093
P2860
P50
P1433
P1476
Establishing a cohort at high ...... ISA 002 acute infection study.
@en
P2093
CAPRISA 002 Acute Infection Study Team
Itua Iriogbe
Nomampondo Barnabas
Sara C Auld
P2860
P356
10.1371/JOURNAL.PONE.0001954
P407
P50
P577
2008-04-16T00:00:00Z